Citadel Advisors »

Lyell Immunopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.9M 394k 20.06
2025-12-31 $11M 341k 30.78
2025-09-30 $5.8M 356k 16.24
2025-06-30 $2.5M 287k 8.84

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding Lyell Immunopharma

Arch Venture Corp
Vanguard Group
Foresite Capital Management IV
Orland Properties
Vanguard Capital Management
Almitas Capital
Foresite Capital Management V
Millennium Management
Citadel Advisors
venBio Partners
Alphabet
BlackRock
Geode Capital Management
Susquehanna International
Sc China Holding

View all funds holding Lyell Immunopharma